Artificial intelligence may mitigate overdiagnosis and unnecessary treatments in cancer care by integrating with precision medicine.
Chandler H. Park, MD, FACP
Advertisement
Articles by Chandler H. Park, MD, FACP
Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
Advertisement
Latest Updated Articles
Artificial Intelligence in Cancer Care: Addressing Challenges and Health EquityPublished: April 15th 2025 | Updated:
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment StrategiesPublished: March 7th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
2
Response Rates Show Promise in Phase 1 Trial Involving ASCT in Metastatic PDAC
3
Case 2: Patient With High-Risk RRMM Relapsing After BCMA CAR T-Cell Therapy
4
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
5
